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ABSTRACT The (X;l)(pll;q21) translocation is a recur­
rent chromosomal abnormality in a subset of human papillary 
renal cell carcinomas, and is sometimes the sole cytogenetic 
abnormality present. Via positional cloning, we were able to 
identify the genes involved. The translocation results in a 
fusion of the transcription factor TFE3 gene on the X chro­
mosome to a novel gene, designated PRCC, on chromosome L 
Through this fusion, reciprocal translocation products are 
formed, which are both expressed in papillary renal cell 
carcinomas. PRCC is ubiquitously expressed in normal adult 
and fetal tissues and encodes a putative protein of 491 aa with 
a relatively high content of prolines. No relevant homologies 
with known sequences at either the DNÀ or the protein level 
were found.
ït is by now well established that recurrent chromosomal 
translocations play a major role in the etiology of cancer (1). 
Based on translocation breakpoint studies in mostly hemato­
poietic tumors, two basic mechanisms have emerged, that can 
lead to (/) the altered expression of protooncogene products or 
(ii) the formation of fusion proteins. In solid tumors, the 
second mechanism seems to be the predominant one. Studies 
on tumor-specific translocations have led to the identification 
of several genes involved, among which are often those en­
coding transcription factors (1).
Chromosome 3 abnormalities are frequently found in spo­
radic and familial cases of clear cell nonpapillary renal cell 
carcinomas (RCCs; ref. 2). For instance, in patients with the 
Von Hippel-Lindau disease, mutations in the VHL gene on 
chromosome 3p were found to be predisposing to several types 
of cancer, including renal cancer (3). Mutations and loss of 
heterozygosity of the VHL gene have also been detected in 
sporadic renal cell carcinomas (4). Recently, another gene on 
chromosome 3 was identified (FHIT) that is disrupted in 
hereditary t(3;8)-positive clear cell nonpapillary renal cancer
(5) and that appears to be a member of the histidine triad gene 
family. In contrast, chromosome 3 abnormalities appear to be 
absent in chromophilic RCCs with a papillary growth pattern, 
commonly referred to as papillary RCCs. Instead, a combi­
nation of gain of chromosomes 7 and 17 and loss of the Y 
chromosome are found (2,6). In addition, a t(X ;l)(p ll;q21) or 
variants thereof have repeatedly been described in a subgroup 
of these tumors (7-13), sometimes as the sole cytogenetic 
anomaly present. Previously, positional cloning strategies were 
used to narrow down the translocation regions, thereby ex­
cluding several candidate genes in X p l l  and lq21 (14,15). We 
now report the identification of the genes that are involved in 
this specific translocation.
M A T E R IA L S  AND M E T H O D S
Tumor Material, Somatic Cell Hybrids, and Tissues. Two
male-derived renal cell cultures (CL89-12117 and CL89-
17872), one male-derived primary tumor (REN11-TT; ref. 9), 
and one female-derived primary tumor (RP-T) were used in 
this study. CL89-12117 and RP-T contain the t(X ;l)  as the only 
cytogenetic abnormality, whereas CL89-17872 also shows nu­
merical aberrations next to the t(X ;l)  (7). The karyotype of 
REN11-TT is as follows: 49,Y ,t(X ;l)(pl l;q21),+der(X )t(X ;l) 
(p ll;q21),+5,-16 ,+  17,+18. R E N ll-N  and RP-N were taken 
as controls and consist of normal tissue adjacent to the 
corresponding tumors. CL89-12117-derivcd somatic cell hy­
brids were obtained as described before (14,16). Briefly, after 
fusion of A3 or Wg3h hamster cell lines and the t(X;l)-positive 
renal carcinoma ceils, a panel of somatic cell hybrids was 
isolated in which the reciprocal translocation chromosomes 
segregate. As controls, two hybrid lines containing the normal 
X chromosome (17) or normal chromosome 1 (GMÎ3.139; 
Coriell Cell Repositories, Camden, NJ) as the only human 
constituent and parental hamster (A3) and mouse (A9) cell 
lines were included, ITL6Ö is a myeloid leukemia cell line. Rat 
organs that were used for Northern blot analysis were: spleen, 
liver, brain, heart, striated muscle, kidney, testes, thymus, 
seminal vesicles, lung, bladder, intestines, and stomach. Blots 
containing 2 fig ol: poly (A)*-selected RNA of fetal tissues 
(brain, lung, liver, and kidney) and adult tissues (heart, brain, 
placenta, lung, liver, skeletal muscle, kidney, and pancreas) 
were purchased from CLONTECIT.
RNA Isolation, Northern Blot Analysis, and Reverse Tran­
scription PCR (RT-PCR), Total RNA was isolated as de­
scribed by Auf fray and Rougeon (18). Oligodeoxythymidine 
selections were performed using oligodeoxythymidine col­
umns (type II; Collaborative Research). Total RNA (10 fig) 
was blotted on Hybond N-plus (Amersham) according to the 
procedure recommended by the manufacturer, after glyoxy- 
iation (19) and size fractionation on 1% agarose gels. RT-PCR 
was perform ed using 5 ßg  of total RNA and Superscript RT 
(Life Technologies, Grand Island, NY) using the conditions as 
described by the manufacturer. Priming was perform ed using 
a specific primer for PRCC  (5 '-G G G G A A G CA A G G CA G A - 
CAAACCA-3') or TFE3 (TFE3b; S '-G G TG G G G TG A G - 
G G CCTG G G A -3'). PCR (30-35 cycles) was perform ed under 
standard conditions using 10 pmol of priming oligonucleotide 
and 10 pmol of a second TFE3-specific primer (TFE3a; 
5 '-CG CG G CTCCCTTCCCCAG TC-3') according to the fol­
lowing protocol: dénaturation at 94°C for 45 sec, annealing at 
60°C (PRCC) or 62°C (TFE3) for 45 sec, and extension at 72°C 
for 1 min.
Construction of the CL89-12117 cDNA Library. A CL89- 
12117-derived cDNA library was constructed from 5 /xg of 
oligodeoxy thymidine-selected RNA into U ni-ZA P XR using a 
unidirectional cDNA cloning kit (Stratagene). The size of the 
primary cDNA library was « 3  X 10h recombinant clones. 
Clones (10(>) of the amplified library were used for screening.
Hybridization, DNA Probes, and Southern Blot Analysis. 
Probes were labeled by random prime labeling and hybridized
The publication costs of this article were defrayed in part by page charge 
payment. This article must therefore be hereby marked “advertisement" in 
accordance with 18 U.S.C §1734 solclv to indicate this fact.
Abbreviations: RCC: renal ccll carcinoma; RT-PCR, reverse tran­
scription PCR; EST, expressed sequence tag.
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A consensus site for tyrosine kinases is also present, indicating 
that this predicted protein may function in a signaling cascade 
and, as such, may contribute to tumor formation as part of a 
fusion product.
Two translocation-related mechanisms for tumor formation 
have been reported: deregulation of the expression of a 
protooncogene without the formation of an altered protein 
and formation of a fusion protein that has transforming 
capacities. In the first case, which is predominantly encoun­
tered in B- and T-cell leukemias and lymphomas, T-cell 
receptor or immunoglobulin genes become juxtaposed to a 
protooncogene, often a transcription factor, thereby activating 
it (1). The second mechanism leads to the formation of fusion 
proteins. In t(X;l)-positive tumors, the open reading frames of 
the two genes involved, TFE3, a transcription factor which 
binds to the /xE3 element of the immunoglobulin enhancer 
(20), and a novel gene, PRCC , are both interrupted, leading to 
the formation of two putative fusion proteins. Since both 
fusion genes are expressed, it remains to be determined if both 
are needed for the establishment of the malignant phenotype 
or if one of them is causally related to malignant transforma­
tion. In addition, an alternative mechanism that may lead to 
transformation cannot be ruled out. Since most patients 
carrying a t(X ;l) reported to date are male, one can speculate 
that loss of function of a gene on the X chromosome might 
represent, a  crucial step in tumor formation. An indication in 
this direction comes from a male patient with papillary RCC 
without an (X ;l) translocation but instead, a deletion in the 
X p ll  region (24). Only two female patients with a t(X ;l) have 
been described so far. One of these patients, who already 
suffered from a kidney tumor at the age of 9 years, developed 
multiple tumors in the right kidney at 29 years of age (J. 
Couturier, personal communication), suggesting that a con­
stitutional mutation may have been present on the X chromo­
some not involved in the translocation. A  cell line which was 
developed from a second female patient did not contain a 
normal X chromosome next to der(X) (21), So, teleologically, 
disruption of the function of TFE3 may be sufficient for 
establishing the malignant phenotype. Further studies are 
needed to reveal which mechanism ultimately leads to the 
formation of this type of renal cell carcinomas. Now that the 
relevant genes have been identified, tools are available to 
determine the molecular events underlying the development of 
t(X;l)-positive papillary renal cell carcinomas.
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